Correlation Between Corvus Pharmaceuticals and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Edgewise Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Edgewise Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Edgewise Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Corvus and Edgewise is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Edgewise Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 1.16 times more return on investment than Edgewise Therapeutics. However, Corvus Pharmaceuticals is 1.16 times more volatile than Edgewise Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 77.00 in Corvus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 832.00 from holding Corvus Pharmaceuticals or generate 1080.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Edgewise Therapeutics
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Edgewise Therapeutics |
Corvus Pharmaceuticals and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Edgewise Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |